Recalls & Warnings November 29, 2019 FDA Warns Seller of "All Natural" Treatment for Opioid Withdrawal, Migraines & More On November 18, 2019, the FDA issued a warning letter to EPH Technologies, Inc., following a review of the company's websites, which found statements made about some of the company's products, including Detoxoplex, Sinople, and Migrenz, to be drug claims
GLP-1 signals the pancreas to produce more insulin when blood sugar levels are high
While its role in established cirrhosis is limited, it might serve as an adjuvant therapy to enhance patient outcomes
Industry experts say that obesity has become a top five global market driver, and MMITs sister company, Evaluate, estimates the obesity opportunity as exceeding $35 billion by 2028
Tap water or mineral water has stuff like calcium and magnesium in it, which can mess with the hyaluronic acid